ReNeuron stem cell therapy shows long-term promise for stroke

April 17, 2015 12:50 PM

12 0

LONDON (Reuters) - A pioneering stem cell treatment for patients disabled by stroke has continued to show long-term promise in a clinical trial, the British biotech company behind the project said on Friday.

News that two-year follow-up data from a small Phase I study showed improvements in limb function with no worrying safety issues lifted shares in ReNeuron 10 percent by 0830 EDT.

Also read: Opioid Addiction Study Finds the Drug Vivitrol, Once Begun, Is as Effective as Suboxone

Read more

To category page